Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00642070 · ClinicalTrials.gov registry record
Host Response to Urinary Tract Infection in Women
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 326
- Enrollment target
NCT00642070: Completed study, sponsored by University of Washington.
NCT00642070 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 326 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00642070 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 326 participants
- Enrollment target
Study Summary
This study is being done to identify those elements of the immune response that may predispose a woman to recurrent urinary tract infection. We suspect that lesser effectiveness of certain components of the host response will lead to recurrent urinary tract infection. We will also evaluate the role that the bladder reservoir may play in recurrent urinary tract infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-07 |
What the finished NCT00642070 record still lists
NCT00642070 is an observational study that tracks outcomes without assigning an intervention. The registered 326 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00642070 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00642070 about?
NCT00642070 is a clinical study titled "Host Response to Urinary Tract Infection in Women". This study is being done to identify those elements of the immune response that may predispose a woman to recurrent urinary tract infection. We suspect that lesser effectiveness of certain components of the host response will lead to recurrent urinary tract infection. We will also evaluate the role ...
What is the current status of trial NCT00642070?
This trial is currently completed. The enrollment target is 326 participants. The study started on 2008-02. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT00642070?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06410144 · 326 participants · NA
Chronic Kidney Disease-Education (CKD-EDU)
- NCT06586619 · 326 participants · NA
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
- NCT07040566 · 326 participants · Phase 2
A Trial of Varenicline for E-cigarette Cessation
- NCT07165860 · 326 participants · NA
Clinical Trial to Reduce Perinatal Intimate Partner Violence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia